To our knowledge, this is the first study to demonstrate the successful functionalization of AuNPs’ surface with NmAb, a humanized anti-EGFR IgG1 mAb that targets EGFR and is used against various EGFR-overexpressing cancers. This evidence concerns the gene EGFR and cancer.